Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 441 to 450 of 1898

TitleReference numberPublishedLast updated
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Intramedullary distraction for upper limb lengtheningIPG722
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781

Results per page

  1. 10
  2. 25
  3. 50
  4. All